+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Direct-to-Consumer (DTC) Genetic Testing - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 324 Pages
  • July 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 2255350

Global Direct-to-Consumer (DTC) Genetic Testing Market to Reach US$1.9 Billion by the Year 2026


Genomic testing is a revolutionary tool and offers a broad range of applications such as diagnosis of infectious diseases, treatment selection for cancer patients, non-invasive prenatal testing, among others. Growth in the global is being driven by new technological advances and rising prevalence of many genetic disorders such as diabetes, cancer, cystic fibrosis, and Alzheimer`s disease globally. Factors such as real time drug discovery, cutting-edge diagnostic methods, and advanced treatments will propel market growth. Increasing user awareness, disposable income, and healthcare expenditure combined with rising adoption of customized medicine to treat genetic disease are other factors driving growth in the market. Public awareness regarding the availability of DTC genetic testing in developing as well as developed countries is continually rising. Leading market players like Ancestry and 23andMe are focusing on offering high-quality DTC genetic testing solutions that ensure accurate and effective test results. Growing awareness among Europeans and Americans regarding racial testing is also driving market demand. Another key driver in the DTC genetic testing market includes elderly consumers who take a keen interest in their healthcare, which is intensified by access to genetic test kits that can detect genes whose variations are associated with an increased risk of developing an age-related disease such as Alzheimer`s. The declining cost of these tests along with the benefits of confidentiality and anonymity further drive growth.

Amid the COVID-19 crisis, the global market for Direct-to-Consumer (DTC) Genetic Testing estimated at US$1.1 Billion in the year 2022, is projected to reach a revised size of US$1.9 Billion by 2026, growing at a CAGR of 12.3% over the analysis period. Ancestry & Relationship Testing, one of the segments analyzed in the report, is projected to grow at a 9.8% CAGR to reach US$915.4 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Nutrigenomics Testing segment is readjusted to a revised 13.6% CAGR for the next 7-year period. This segment currently accounts for a 21% share of the global Direct-to-Consumer (DTC) Genetic Testing market. Ancestry & relationship testing is the most prevalent test type, and the segment is slated to benefit from recent advances that are likely to link ancestry testing with health-related genetic testing. Nutrigenomics testing is used by healthcare professionals to suggest personalized diet and nutritional guidance to overweight people to maintain a healthy lifestyle and manage weight. The segment`s growth is propelled by rising prevalence of obesity and increasing R&D related to nutritional aspects.

The U.S. Market is Estimated at $478.5 Million in 2022, While China is Forecast to Reach $149.8 Million by 2026


The Direct-to-Consumer (DTC) Genetic Testing market in the U.S. is estimated at US$478.5 Million in the year 2022. The country currently accounts for a 43% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$149.8 Million in the year 2026 trailing a CAGR of 15.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.3% and 13.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR while Rest of European market (as defined in the study) will reach US$170.8 Million by the end of the analysis period. The US dominates market growth due to the increased awareness about genetic diseases among general populace, growing tendency among general public to identify early and either prevent or provide management of various chronic diseases as well as technical and scientific advancements made in the field of medicine and science in general. Additionally, the regulatory mechanism in the US is relatively better streamlined compared to other markets. Europe represents the next leading market for DTC genetic testing. The market is fueled by increasing healthcare spending by various governments to ensure easy access to advanced genetic tests.

Predictive Testing Segment to Reach $373.2 Million by 2026


The predictive testing market is recording strong growth, driven by exponential growth in the number of diseases and medical conditions that are identifiable through genetic modalities, surging from a mere 90-100 diseases in the early 1990s, to about 1,800 to 2,000 conditions in the present day. In the global Predictive Testing segment, USA, Canada, Japan, China and Europe will drive the 16.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$134.3 Million will reach a projected size of US$371 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$20.3 Million by the year 2026.

Select Competitors (Total 81 Featured):

  • 23andMe, Inc.
  • Ancestry.com, LLC
  • Any Lab Test Now
  • Color Health, Inc.
  • Direct Laboratory Services, LLC
  • DNA Diagnostics Center
  • Easy DNA
  • Full Genomes Corporation, Inc.
  • Gene by Gene, Ltd.
  • Genesis Healthcare
  • Helix OpCo LLC
  • Laboratory Corporation of America® Holdings
  • Living DNA
  • Mapmygenome India Limited
  • MyHeritage
  • OmeCare
  • Positive Bioscience, Inc.
  • Quest Diagnostics, Inc.
  • Request A Test, Ltd.
  • Sonora Quest Laboratories LLC
  • Xcode Life Sciences

What`s New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to the digital archives
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • A Prelude to Genetic Testing
  • Top Ten Genetic Diseases Worldwide
  • Different Types of Genetic Tests include
  • List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
  • Direct-to-Consumer (DTC) Genetic Testing - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • A Prelude to Direct-to-Consumer (DTC) Genetic Testing
  • Pros and Cons of Direct-to-Consumer (DTC) Genetic Testing
  • Health Information provided by DTC genetic Tests
  • DTC Genetic Tests’ Limitations
  • Market Segments
  • Ancestry Tests
  • Predictive Tests
  • Carrier Tests
  • Nutrigenomics Tests
  • Impact of Covid-19 on Market Prospects of DTC Genetic Testing Companies
  • Market Prospects and Outlook
  • US and Europe Dominate the Global DTC Genetic Tests Market
  • Ancestry Testing Holds Major Share, Predictive Testing Witnesses Rapid Growth
  • Competitive Scenario
  • Recent Market Activity
  • Changing Landscape of DTC Genetic Testing
  • Regulations to Determine Market Viability
  • US FDA Regulations for DTC Genetic Testing
  • Data Privacy Concerns to Challenge Market Prospects
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Consumers Self-Managing Treatments: The New Trend Driving the DTC Genetic Testing Market
  • DTC Genetic Testing Players Join War against COVID-19
  • DTC Genetic Tests for Cancer Susceptibility
  • Worldwide Breast Cancer Incidence and Mortality Rates by Region: 2018
  • Advances in Genome Sequencing
  • Next-Generation Sequencing (NGS) Aids DTC Genetic Testing Market
  • DTC Genetic Testing Presents Lucrative Personalization Opportunities
  • Growing Focus on Service Personalization Generates Opportunities for DTC Genetic Tests
  • Immense Popularity of Ancestry Testing
  • Emergence of DNA-based Nutrition Plans Put the Spotlight on DTC Nutrigenetics Testing
  • Biomarker Discovery Leads to Advanced Genetic Testing
  • Select List of Available Tumor Markers
  • Hybrid Approach of Genetic Testing to Bridge Gap Between Traditional and DTC Models
  • Oncology - A Key Focus Area for Genetic Testing
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Ageing Demographics to Drive Demand for Genetic Testing
  • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
  • Increased Demand for Online Sales of DTC Genetic Tests
  • Use of Artificial Intelligence Adds Value to DTC Genetic Testing Market
4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS
UNITED STATES
  • Direct-to-Consumer (DTC) Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
CANADA
JAPAN
  • Direct-to-Consumer (DTC) Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
CHINA
  • Direct-to-Consumer (DTC) Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
EUROPE
  • Direct-to-Consumer (DTC) Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Advantages of Liberalization of DTC Genetic Testing Regulations
  • EU Policymakers Need to Liberalize Regulations and Create Single Market for DTC Genetic Testing
FRANCE
  • Direct-to-Consumer (DTC) Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
GERMANY
  • Direct-to-Consumer (DTC) Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
ITALY
UNITED KINGDOM
  • Direct-to-Consumer (DTC) Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Direct-to-Consumer (DTC) Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
  • Primary Issues Faced by DTC Genetic Testing in India
REST OF WORLD
IV. COMPETITION
  • Total Companies Profiled: 81

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 23andMe, Inc.
  • Ancestry.com, LLC
  • Any Lab Test Now
  • Color Health, Inc.
  • Direct Laboratory Services, LLC
  • DNA Diagnostics Center
  • Easy DNA
  • Full Genomes Corporation, Inc.
  • Gene by Gene, Ltd.
  • Genesis Healthcare
  • Helix OpCo LLC
  • Laboratory Corporation of America® Holdings
  • Living DNA
  • Mapmygenome India Limited
  • MyHeritage
  • OmeCare
  • Positive Bioscience, Inc.
  • Quest Diagnostics, Inc.
  • Request A Test, Ltd.
  • Sonora Quest Laboratories LLC
  • Xcode Life Sciences